Evidence map›Paper›PMID 34041745›Full record

SynthesisImmunology2021

The diversity of the plasmablast signature across species and experimental conditions: A meta-analysis.

Alexis Grasseau, Marina Boudigou, Magalie Michée-Cospolite, Céline Delaloy, Olivier Mignen, Christophe Jamin, Divi Cornec, Jacques-Olivier Pers, Laëtitia Le Pottier, Sophie Hillion

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. A who's who of cell types in skeletal muscle.Communications biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Alexis GrasseauUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Marina BoudigouUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Magalie Michée-CospoliteUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Céline DelaloyUMR U1236, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Université de Rennes 1, Rennes, France.
Olivier MignenUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Christophe JaminUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Divi CornecUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Jacques-Olivier PersUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Laëtitia Le PottierUMR1227, LBAI, INSERM, Univ Brest, Brest, France.
Sophie HillionUMR1227, LBAI, INSERM, Univ Brest, Brest, France.ORCID 0000-0002-3354-0981
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-secreting cells (ASC) are divided into two principal subsets, including the long-lived plasma cell (PC) subset residing in the bone marrow and the short-lived subset, also called plasmablast (PB). PB are described as a proliferating subset circulating through the blood and ending its differentiation in tissues. Due to their inherent heterogeneity, the molecular signature of PB is not fully established. The purpose of this study was to decipher a specific PB signature in humans and mice through a comprehensive meta-analysis of different data sets exploring the PB differentiation in both species and across different experimental conditions. The present study used recent analyses using whole RNA sequencing in prdm1-GFP transgenic mice to define a reliable and accurate PB signature. Next, we performed similar analysis using current data sets obtained from human PB and PC. The PB-specific signature is composed of 155 and 113 genes in mouse and human being, respectively. Although only nine genes are shared between the human and mice PB signature, the loss of B-cell identity such as the down-regulation of PAX5, MS4A1, (CD20) CD22 and IL-4R is a conserved feature across species and across the different experimental conditions. Additionally, we observed that the IRF8 and IRF4 transcription factors have a specific dynamic range of expression in human PB. We thus demonstrated that IRF4/IRF8 intranuclear staining was useful to define PB in vivo and in vitro and able to discriminate between atypical PB populations and transient states.

Indexed as

AnimalsAntibody-Producing CellsAntigens, CD20B-LymphocytesCell DifferentiationGlycoproteinsHumansMiceMice, TransgenicPAX5 Transcription FactorPlasma CellsPositive Regulatory Domain I-Binding Factor 1Sequence Analysis, RNATranscriptomeWhole Genome SequencingAntigens, CD20GlycoproteinsMS4A1 protein, humanPAX5 protein, humanPAX5 Transcription FactorPositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseB-cell differentiationmeta-analysisplasmablasttranscriptome

Identifiers

PMID34041745
PMCPMC8358713
OpenAlexW3165490488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.